Partnership with Professor Woei-Jer Chuang of NCKU to explore AI-powered discovery in protein drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with NCKU Taipei | [October 27, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI for drug discovery, today announced the signing of a Memorandum of Understanding (MOU) with Professor Woei-Jer Chuang, Ph.D., of the Department of Biochemistry and Molecular Biology, Na

We're excited to share that a recent academic paper co-authored by our Data Scientist. Ling-Yu Cai, along with a team of MD/PhD...

Expanding Global Reach with Kolr's Rebranding and Cutting-Edge AI Technologies (Left to right) Vizuro Co-founder and CEO, Yu-Feng Wei;...